Life Sciences Partners (LSP) of the Netherlands has raised an additional €150 million for its LSP 7 fund, bringing the total amount for investment up to €1 billion. This represents the final close of one of the largest venture funds in Europe. The monies will be used to invest in 15 to 20 companies which are developing new drug therapies and medical technologies, LSP said on 11 February.
